NewGenIvf Group annual capital expenditures (capex)
2021
2022
2023
2024
2025
NewGenIvf Group Capital Expenditures (CapEx) Growth & History (NIVF)
NewGenIvf Group's capital expenditures (capex) was $135,025 for fiscal 2025.
View full NewGenIvf Group company overviewNewGenIvf Group annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $135,025 | $81,980 | +154.55% |
| 2024 | 2024-12-31 | $53,045 | −$16,803 | −24.06% |
| 2023 | 2023-12-31 | $69,848 | −$24,604 | −26.05% |
| 2022 | 2022-12-31 | $94,452 | $77,877 | +469.85% |
| 2021 | 2021-12-31 | $16,575 | — | — |
NewGenIvf Group capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, NewGenIvf Group's capital expenditures (capex) increased from $16,575 to $135,025, a change of $118,450.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NewGenIvf Group source filings ↗